1.Diagnostic Peritoneal Lavage.
Sang Moon PARK ; Joon Seok PARK ; Myung Gon RYU ; Kab Deuk KIM ; Wha Shik SONG ; Jong Wan KIM
Journal of the Korean Society of Emergency Medicine 1998;9(4):622-628
Diagnostic peritoneal lavage is a accurate and safe method confirming the intraabdominal injury with head trauma, unstable multiple injuried patients. But the development of imaging technique and the trend in noninvasive diagnostic value is decreasing now. In the emergency room, the emergency physicians are required the rapidity and accuracy' in intial assessment and the decisions for the operation or not. So emergency physicians have been investigating the diagnostic method for intraabdomial injury that is more rapid, safe and accurate. Many diagnostic tools are developed and now accepted and used widely, among them the diagnostic peritoneal lavage is still the best method for unsatble or head injuries patients. But the positive diagnostic criterias are variable by many authors and still remain imperfectly. So our study was reviewed by medical record of patients who were undertaken the diagnostic peritoneal lavage for the diagnosis intraabdominal injury and statistical analyasis was done compared with many criteria of red blood cell and white blood cell for the more actuate way. A retrospective study of diagnostic peritoneal lavage was done of 90 patients with blunt abdominal trauma during 2 years from January, 1996 to December, 1997 and summerized our experience. The results were as follows; 1) There are 73 males and 17 females in sex. The most common type of injury was the traffic accident. 2) With many variable criteria of RBC and WBC, the accuracy and the false positive and false negative were not different in statistical results. The average accuracy was 80.1%. 3) The operations were done in 30(33.3%) cases, and the most frequent injuried organ was the small bowel, 20 cases(66.7%).
Accidents, Traffic
;
Craniocerebral Trauma
;
Diagnosis
;
Emergencies
;
Emergency Service, Hospital
;
Erythrocytes
;
Female
;
Humans
;
Leukocytes
;
Male
;
Medical Records
;
Peritoneal Lavage*
;
Retrospective Studies
2.Near-Infrared Fluorescence Imaging Using a Protease-Specific Probe for the Detection of Colon Tumors.
Soon Man YOON ; Seung Jae MYUNG ; Byong Duk YE ; In Wha KIM ; Nam Gon LEE ; Yeon Mi RYU ; Kyeongsoon PARK ; Kwangmeyung KIM ; Ick Chan KWON ; Young Soo PARK ; Chan Sik PARK ; Dae Hyuk MOON ; Do Hoon KIM ; Mi Young DO ; Jeong Sik BYEON ; Suk Kyun YANG ; Jin Ho KIM
Gut and Liver 2010;4(4):488-497
BACKGROUND/AIMS: Early tumor detection is crucial for the prevention of colon cancer. Near-infrared fluorescence (NIRF) imaging using a target-activatable probe may permit earlier disease detection. Matrix metalloproteinases (MMPs) participate in tumorigenesis and tumor growth. The aim of this study was to determine whether NIRF imaging using an MMP-activatable probe can detect colon tumors at early stages. METHODS: We utilized two murine colon cancer models: a sporadic colon cancer model induced by azoxymethane (AOM), and a colitis-associated cancer model induced by a combination of AOM and dextran sodium sulfate (DSS). Colonic lesions were analyzed by histologic examination, Western blotting, immunohistochemical staining, and NIRF imaging using an MMP-activatable probe. RESULTS: Multiple variable-sized tumors developed in both models and progressed from adenomas to adenocarcinomas over time. At the early stage of the AOM/DSS model, diffuse inflammation was observed within the tumors. MMP expression increased progressively through normal, inflammation, adenoma, and adenocarcionoma stages. NIRF signal intensities were strongly correlated with each tumor stage from adenoma to adenocarcinoma. NIRF imaging also distinguished tumors from inflamed mucosa. CONCLUSIONS: NIRF imaging using a protease-activatable probe may be a useful tool for early tumor detection. This approach could translate to improve the endoscopic detection of colon tumors, especially in patients with inflammatory bowel disease.
Adenocarcinoma
;
Adenoma
;
Azoxymethane
;
Blotting, Western
;
Cell Transformation, Neoplastic
;
Colon
;
Colonic Neoplasms
;
Dextrans
;
Fluorescence
;
Humans
;
Inflammation
;
Inflammatory Bowel Diseases
;
Matrix Metalloproteinases
;
Optical Imaging
;
Sodium
;
Sulfates
3.Ursodeoxycholic Acid Induces Death Receptor-mediated Apoptosis in Prostate Cancer Cells.
Won Sup LEE ; Ji Hyun JUNG ; Radha PANCHANATHAN ; Jeong Won YUN ; Dong Hoon KIM ; Hye Jung KIM ; Gon Sup KIM ; Chung Ho RYU ; Sung Chul SHIN ; Soon Chan HONG ; Yung Hyun CHOI ; Jin Myung JUNG
Journal of Cancer Prevention 2017;22(1):16-21
BACKGROUND: Bile acids have anti-cancer properties in a certain types of cancers. We determined anticancer activity and its underlying molecular mechanism of ursodeoxycholic acid (UDCA) in human DU145 prostate cancer cells. METHODS: Cell viability was measured with an MTT assay. UDCA-induced apoptosis was determined with flow cytometric analysis. The expression levels of apoptosis-related signaling proteins were examined with Western blotting. RESULTS: UDCA treatment significantly inhibited cell growth of DU145 in a dose-dependent manner. It induced cellular shrinkage and cytoplasmic blebs and accumulated the cells with sub-G1 DNA contents. Moreover, UDCA activated caspase 8, suggesting that UDCA-induced apoptosis is associated with extrinsic pathway. Consistent to this finding, UDCA increased the expressions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor, death receptor 4 (DR4) and death receptor 5 (DR5), and TRAIL augmented the UDCA-induced cell death in DU145 cells. In addition, UDCA also increased the expressions of Bax and cytochrome c and decreased the expression of Bcl-xL in DU145 cells. This finding suggests that UDCA-induced apoptosis may be involved in intrinsic pathway. CONCLUSIONS: UDCA induces apoptosis via extrinsic pathway as well as intrinsic pathway in DU145 prostate cancer cells. UDCA may be a promising anti-cancer agent against prostate cancer.
Apoptosis*
;
Bile Acids and Salts
;
Blister
;
Blotting, Western
;
Caspase 8
;
Cell Death
;
Cell Survival
;
Cytochromes c
;
Cytoplasm
;
DNA
;
Humans
;
Necrosis
;
Prostate*
;
Prostatic Neoplasms*
;
Receptors, TNF-Related Apoptosis-Inducing Ligand
;
Ursodeoxycholic Acid*
4.Anthocyanins From the Fruit of Vitis coignetiae Pulliat Potentiate the Cisplatin Activity by Inhibiting PI3K/Akt Signaling Pathways in Human Gastric Cancer Cells.
Jing Nan LU ; Won Sup LEE ; Arulkumar NAGAPPAN ; Seong Hwan CHANG ; Yung Hyun CHOI ; Hye Jung KIM ; Gon Sup KIM ; Chung Ho RYU ; Sung Chul SHIN ; Jin Myung JUNG ; Soon Chan HONG
Journal of Cancer Prevention 2015;20(1):50-56
BACKGROUND: Cisplatin (cis-diaminedichloroplatinum, CDDP) is a widely used chemotherapeutic agent for the treatment of many cancers. However, initial resistance to CDDP is a serious problem in treating these cancers. Vitis coignetiae Pulliat (Meoru in Korea) have shown anti-nuclear factor kappa B and anti-epidermal growth factor receptor activities in cancer cells. METHODS: In this study, in order to seeking an approach to increase the anti-cancer effects of CDDP with natural products. Here, we investigated anthocyanins isolated from Vitis coignetiae Pulliat (anthocyanidins isolated from meoru, AIMs) can enhance anti-cancer effects of cisplatin (CDDP) in stomach cancer cells. The cell viability of SNU-1 and SNU-16 cells after treated with AIMs and CDDP were analyzed by MTT assay. The expressions of Akt and X-linked inhibitor of apoptosis protein (XIAP) proteins were examined by western blot in AIMs- and CDDP-treated cells. RESULTS: We found that AIMs enhanced anticancer effects of CDDP, which activity was additive but not synergistic. AIMs suppressed Akt activity of the cancer cells activated by CDDP. AIMs also suppressed in XIAP an anti-apoptotic protein. CONCLUSIONS: This study suggests that the anthocyanins isolated from fruits of Vitis coignetiae Pulliat enhanced anti-cancer effects of CDDP by inhibiting Akt activity activated by CDDP.
Anthocyanins*
;
Biological Products
;
Blotting, Western
;
Cell Survival
;
Cisplatin*
;
Fruit*
;
Humans*
;
Stomach Neoplasms*
;
Vitis*
;
X-Linked Inhibitor of Apoptosis Protein